Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells. (Q52951378)

9 May 2018

title

Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells. (English)

1 reference

9 May 2018

1 reference

1

1 reference

9 May 2018

Martin Köbel

4

1 reference

9 May 2018

author name string

Ines Koch

2

1 reference

9 May 2018

Stefan Berger

3

1 reference

9 May 2018

Antje Siegert

5

1 reference

9 May 2018

Steffen Hauptmann

6

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

9 May 2018

published in

Cancer Letters

1 reference

9 May 2018

volume

195

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

101-109

1 reference

9 May 2018

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Reconstitution of novel signalling cascades responding to cellular stresses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Inhibition of p38 MAP kinase as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

The primary structure of p38 gamma: a new member of p38 group of MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

Specificity and mechanism of action of some commonly used protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900052-1

7 January 2021

10.1016/S0304-3835(03)00052-1

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

12767518

1 reference

9 May 2018